Board Meeting16 Oct 2026, 12:23 pm
Corona Remedies Board Meeting on Oct 30 for Q2 FY27 Results
AI Summary
Corona Remedies Ltd has announced that its Board of Directors will convene on October 30, 2026, to consider and approve the Unaudited Financial Results for the second quarter and half year ended September 30, 2026. The results will be presented on both a standalone and consolidated basis. The trading window for the company's securities will remain closed until November 1, 2026.
Key Highlights
- Board meeting scheduled for October 30, 2026.
- To approve Unaudited Financial Results for Q2 and H1 FY27.
- Results to be considered on standalone and consolidated basis.
- Trading window closure extended until November 1, 2026.
Price Impact
More from CORONA